Travere Therapeutics to Report Fourth Quarter and Full Year 2024 Financial Results
February 08 2024 - 4:30PM
Travere Therapeutics, Inc. (NASDAQ: TVTX) today announced it will
report fourth quarter and full year 2023 financial results on
Thursday, February 15, 2024, after the close of the U.S. financial
markets. The Company will host a conference call and webcast to
discuss the financial results and provide a general business update
at 4:30 p.m. ET.
The webcast and dial-in information can be accessed on the
Investor page of Travere’s website at
ir.travere.com/events-presentations. Following the live webcast, an
archived version of the call will be available for 30 days on the
Company’s website.
About Travere Therapeutics
At Travere Therapeutics, we are in rare for
life. We are a biopharmaceutical company that comes together every
day to help patients, families, and caregivers of all backgrounds
as they navigate life with a rare disease. On this path, we know
the need for treatment options is urgent – that is why our global
team works with the rare disease community to identify, develop,
and deliver life-changing therapies. In pursuit of this mission, we
continuously seek to understand the diverse perspectives of rare
patients and to courageously forge new paths to make a difference
in their lives and provide hope – today and tomorrow. For more
information, visit travere.com.
Investors:888-969-7879ir@travere.com |
Media:888-969-7879mediarelations@travere.com |
Travere Therapeutics (NASDAQ:TVTX)
Historical Stock Chart
From Aug 2024 to Sep 2024
Travere Therapeutics (NASDAQ:TVTX)
Historical Stock Chart
From Sep 2023 to Sep 2024